Women's Health

FDA Approves Historic First At-Home Breast Cancer Genetic Test

The consumer can choose whether or not they'd like to see BRCA mutation status

When a consumer purchases the at-home test by 23andME, they can choose if they wish to review the various reports generated on their behalf, including access to a report about their BRCA mutation status. “This is an important step—one that we need to be very careful about, moving forward. There is a wide spectrum of the importance of those mutations. Only a very small number are important for making informed clinical decisions,” said Dr. Stephen Chanock, director of the Division of Cancer Epidemiology and Genomics at the National Cancer Institute.